Agenda At-a-glance

SESSION A

Track 1

Changing the Landscape for Cell and Gene Therapy
Maryland’s Center of Excellence

Moderator:
Margot Connor, Chief Executive Officer, RoosterBio

Panelists:
Emily English, Ph.D., Chief Executive Officer, Gemstone Therapeutics
Kimberly Noonan, Ph.D., Founder, Executive Vice President and Chief Scientific Officer, WindMIL Therapeutics
William Rust, Ph.D., Chief Executive Officer and Co-Founder, Seraxis

Track 2

The Friends and Family Plan
Experts discuss different levels of early stage fundraising

Moderator:
Jeff Galvin, Chief Executive Officer and Founder, American Gene Technologies

Panelists:
Judy Costello, Managing Director, Economic Development, BioHealth Innovation
Henry Ahn, SBIR/STTR Program Director, National Science Foundation
Joseph Naft, Director, Maryland Industrial Partnerships (MIPS) Program
Paul Silber, Founding Principal, Blu Venture Investors

Keynote Address
Hopes for a Cure – Gene Therapy for Sickle Cell Anemia

Keynote Speaker:
John F. Tisdale, M.D., Chief, Cellular and Molecular Therapeutics Branch, National Heart, Lung, and Blood Institute, National Institutes of Health

SESSION B

Track 1

Life Saving Therapies, Heart Stopping Prices
Navigating Reimbursement

Panelists:
Brian Abraham, Director,Market Access, Life Sciences, BDO

Track 2

Employment Opportunities Fulfilled
The demand for life sciences job skills is growing rapidly in this region. Our roundtables will discuss opportunities and challenges while determining actions which can be taken to ensure workforce readiness and availability for the near-, mid- and long-term.

Moderators:
Sarah Sheppard, Director of Education and Workforce, Office of Strategic Industries and Entrepreneurship, Maryland Department of Commerce

Roundtable Discussion Leaders:
Shiva Fritsch, Senior Vice President of Human Resources, REGENXBIO
Brian Gaines, Chief Executive Officer, Learning Undefeated

Networking Lunch in the Exhibit Hall
BIO Partnering Meetings

SESSION C

Track 1

Novel Therapies, Regulatory Realities

Moderator:
Michael Druckman, Partner, Washington, D.C., Hogan Lovells

Panelists:
David Feigal, M.D., MPH, Partner, NDA Partners
Randy Prebula, Partner, Washington, D.C., Hogan Lovells

Track 2

Strategic Market Planning for Capital and Commercialization
Experts discuss key considerations and timing for market assessments to drive strategic partnering options and optimized commercial launch success

Sponsored by

Moderator:
Steven Walker, MBA, MHA, Chief Business Officer and Commercial Strategist, Biologics Consulting

Panelists:
Luis Gutierrez, Past President, Commercialization Services, Covance
Ram Palanki, Pharm.D., Senior Vice President of Commercial Strategy and Operations, REGENXBIO
Tyrell Rivers, Ph.D., Executive Director of Corporate Development, AstraZeneca

SESSION D

Track 1

New Frontiers of Biomanufacturing

Moderator:
Martin Rosendale, Chief Executive Officer, Maryland Tech Council

Panelists:
Jeffrey Hung, Ph.D.,Chief Commercial Officer, Vigene Biosciences, Inc.
Christopher McDonald, Vice President of Manufacturing, Kite Pharma
Jon Rowley, Ph.D., Founder and Chief Product Officer, RoosterBio
Aaron Vernon, Vice President, Engineering and Supply Chain, Autolus

Track 2

Past Seed Stage to the Last Mile
Experts discuss later stage fundraising opportunities

Moderator:
Linda Segal, Principal, The McCormick Group

Panelists:
Subhendu Basu, Ph.D., Chief Operating Officer, Adaptive Phage Therapeutics
Diana Bernstein, Ph.D., Senior Associate, MRL Ventures
Pete Buzy, President, Paragon Gene Therapy, Catalent Biologics
R. Jacob Vogelstein, General Partner, Camden Partners

Keynote Address

Cocktail Reception